Government urged to sustain current tax break system for domestic technical transfer income

Published: 2003-11-11 07:00:00

Updated: 2003-11-11 07:00:00

Following the recent move of Ministry of Finance and Economy to abolish the tax breaks of technical transfer income of domestic pharmaceutical makers in its tax revision, which has been submitted to the National Assembly, domestic pharmaceutical industry has feared that the proposed exemption of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK